NTLA
Intellia Therapeutics Inc.
$17.26
+$1.67(+10.71%)
58
Overall
--
Value
58
Tech
--
Quality
Market Cap
$1.67B
Volume
8.88M
52W Range
$5.90 - $21.94
Target Price
$32.78
Key Metrics Overview
| Market Cap | $1.67B | P/E Ratio | N/A |
| 52W High | $21.94 | 52W Low | $5.90 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 0.0% | 52W Position | 70.8% |
| Overall Score | 58 | Value Score | -- |
| Quality Score | -- | Technical Score | 58 |
Growth Analysis
| EPS Current Est | $-4.09 | EPS Next Est | $-3.98 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NTLA | $17.26 | +10.7% | 8.88M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Intellia Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW